FDA approves pill to treat deadly C. difficile infections
By
Alicia Lasek
Apr 28, 2023
The first-of-its-kind fecal microbiota pill treats recurrent infections caused by Clostridium difficile, an antibiotic-resistant bacterium that’s a danger to nursing home residents.
C. diff vaccine moves closer to reality with launch of large Phase III trial
By
Tim Mullaney
May 19, 2014
A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes...
FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff
By
McKnight's Staff
Jun 19, 2013
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers,...
FDA — full of poop?
By
Jacqueline Vance, RNC, CDONA/LTC
Jun 11, 2013
Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.
Fecal transplants to treat C. diff now need FDA approval
By
McKnight's Staff
May 17, 2013
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.